Skip to content
OpenCapital
Get started

Perrigo Company PRGO Digestive Health — Net Sales

Other product segments

Oral Care
$354.4M-5.4%
Upper Respiratory
$197.4M-8.1%
Skin Health
$151.9M—
Healthy Lifestyle
$142.7M-9.1%
Pain & Sleep
$106.6M—
Women's Health
$55.1M+11.3%

Similar metrics at other companies

PBH
PBHGastrointestinal — Total revenues
$68.35M-0.8%
Balchem logo
BCPCHuman Nutrition and Health — Net Sales
$171.63M+8.3%
PBH
PBHNet sales — Total revenues
$278.66M-5.9%
Avanos Medical logo
AVNSEnteral feeding — Net Sales
$84.6M+13.6%
Balchem logo
BCPCAnimal Nutrition and Health — Net Sales
$62.19M+8.6%
Clorox logo
CLXHealth and Wellness — Net Sales
$629M-0.2%

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-62.9%
Enterprise value$4.82B-32.0%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's digestive health — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's digestive health — net sales?
Perrigo Company (PRGO) reported digestive health — net sales of $96.6M in Q1 2026.
How has Perrigo Company's digestive health — net sales changed year-over-year?
Perrigo Company's digestive health — net sales decreased by 14.4% year-over-year, from $112.9M to $96.6M.
What is the long-term trend for Perrigo Company's digestive health — net sales?
Over 4 years (2021 to 2025), Perrigo Company's digestive health — net sales has grown at a -1.1% compound annual growth rate (CAGR), from $504.3M to $482.6M.
What does digestive health — net sales mean?
This metric represents the total revenue generated from the sale of products within the company's digestive health portfolio, including over-the-counter remedies and related therapeutic solutions. It serves as a key indicator of market demand and brand performance within the gastrointestinal health category. Tracking these sales helps investors assess the segment's contribution to overall top-line growth and its competitive positioning in the consumer healthcare market.